Want to boost power when controlling FDR by using more than just the p-value? We benchmarked several recent FDR methods to evaluate performance, applicability, consistency, and usability in computational biology. Here's our practical guide: biorxiv.org/content/early/…

Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular Tools ascopubs.org/doi/full/10.12…

Should the pCR rate, a frequent endpoint in early breast cancer neoadjuvant studies, be used to compare treatment efficacy across different trials? The I-SPY consortium has developed the Treatment Efficacy Score (TES) as a more relevant surrogate annalsofoncology.org/article/S0923-…

The systematic analysis of isozyme expression patterns in cancer by Michal Marczyk et al, elucidates an important aspect of cancer metabolic plasticity and reveals putative metabolic vulnerabilities. bit.ly/3FmVwgo